{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:52:47Z","timestamp":1789872767087,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bbr.2018.08.006","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T12:48:57Z","timestamp":1533818937000},"page":"271-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"special_numbering":"C","title":["Neural correlates of liraglutide effects in persons at risk for Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"356","author":[{"given":"Kathleen T.","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonita E.","family":"Wroolie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabby","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara C.","family":"Foland-Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Frangou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siena","family":"Roat-Shumway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Myoraku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan L.","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie L.","family":"Rasgon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2018.08.006_bib0005","series-title":"Alzheimer\u2019s Disease Facts and Figures","year":"2018"},{"key":"10.1016\/j.bbr.2018.08.006_bib0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/epirev\/mxs012","article-title":"Type 2 diabetes as a risk factor for Alzheimer\u2019s disease: the confounders, interactions, and neuropathology associated with this relationship","volume":"35","author":"Vagelatos","year":"2013","journal-title":"Epidemiol. Rev."},{"issue":"3","key":"10.1016\/j.bbr.2018.08.006_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S2213-8587(13)70048-2","article-title":"Risk score for prediction of 10\u2009year dementia risk in individuals with type 2 diabetes: a cohort study","volume":"1","author":"Exalto","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.bbr.2018.08.006_bib0020","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","article-title":"Brain metabolic dysfunction at the core of Alzheimer\u2019s disease","volume":"88","author":"de la Monte","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2018.08.006_bib0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13300-016-0180-0","article-title":"Clinical effectiveness of liraglutide in type 2 diabetes treatment in the real-world setting: a systematic literature review","volume":"7","author":"Ostawal","year":"2016","journal-title":"Diabetes Ther."},{"issue":"1","key":"10.1016\/j.bbr.2018.08.006_bib0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12017-012-8199-5","article-title":"The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-beta plaque and glial pathology in a mouse model of Alzheimer\u2019s disease","volume":"15","author":"Long-Smith","year":"2013","journal-title":"Neuromolecular Med."},{"issue":"Pt A","key":"10.1016\/j.bbr.2018.08.006_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer\u2019s disease","volume":"76","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2018.08.006_bib0040","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-143090","article-title":"The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated Mouse Model of Alzheimer\u2019s disease","volume":"46","author":"Hansen","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.bbr.2018.08.006_bib0045","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2012.04.009","article-title":"Liraglutide protects against amyloid-beta protein-induced impairment of spatial learning and memory in rats","volume":"34","author":"Han","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2018.08.006_bib0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fnene.2013.00002","article-title":"Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain","volume":"5","author":"Gejl","year":"2013","journal-title":"Front. Neuroenergetics"},{"issue":"3","key":"10.1016\/j.bbr.2018.08.006_bib0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.neurobiolaging.2012.06.006","article-title":"Fasting plasma insulin and the default mode network in women at risk for Alzheimer\u2019s disease","volume":"34","author":"Kenna","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.bbr.2018.08.006_bib0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.bbr.2018.08.006_bib0065","first-page":"665","article-title":"Memory functioning questionnaire (MFQ)","volume":"24","author":"Gilewski","year":"1988","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.bbr.2018.08.006_bib0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol Neurosurg. Psychiatry"},{"issue":"Suppl. 20","key":"10.1016\/j.bbr.2018.08.006_bib0075","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbr.2018.08.006_bib0080","series-title":"Revised Visual Retention Test","author":"Benton","year":"1974"},{"key":"10.1016\/j.bbr.2018.08.006_bib0085","series-title":"Manual for the California Verbal Learning Test-Second Edition (CVLT-II)","author":"Delis","year":"2000"},{"key":"10.1016\/j.bbr.2018.08.006_bib0090","series-title":"Delis-Kaplan Executive Function System (D-KEFS)","author":"Delis","year":"2001"},{"key":"10.1016\/j.bbr.2018.08.006_bib0095","first-page":"286","article-title":"L\u2019examen psychologique dans les cas d\u2019encephalopathie traumatique","volume":"28","author":"Rey","year":"1941","journal-title":"Archives de Psychologie"},{"issue":"3","key":"10.1016\/j.bbr.2018.08.006_bib0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1037\/h0061266","article-title":"The Purdue pegboard; norms and studies of reliability and validity","volume":"32","author":"Tiffin","year":"1948","journal-title":"J. Appl. Psychol."},{"key":"10.1016\/j.bbr.2018.08.006_bib0105","series-title":"Wechsler Adult Intelligence Scale-3rd Edition (WAIS-III)","author":"Corporation","year":"1997"},{"key":"10.1016\/j.bbr.2018.08.006_bib0110","series-title":"Weschsler Abbreviated Scale of Intelligence (WASI)","author":"Corporation","year":"1999"},{"issue":"2","key":"10.1016\/j.bbr.2018.08.006_bib0115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/nimg.2002.1132","article-title":"Improved optimization for the robust and accurate linear registration and motion correction of brain images","volume":"17","author":"Jenkinson","year":"2002","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.bbr.2018.08.006_bib0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hbm.10062","article-title":"Fast robust automated brain extraction","volume":"17","author":"Smith","year":"2002","journal-title":"Hum. Brain Mapp."},{"issue":"3","key":"10.1016\/j.bbr.2018.08.006_bib0125","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.neuroimage.2011.10.018","article-title":"Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion","volume":"59","author":"Power","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbr.2018.08.006_bib0130","unstructured":"Center for Morphometric Analysis [cited 2018 May 3]; Available from: http:\/\/www.cma.mgh.harvard.edu\/."},{"issue":"Suppl 1","key":"10.1016\/j.bbr.2018.08.006_bib0135","article-title":"Low dose liraglutide in Indian patients with type 2 diabetes in the real world setting","volume":"17","author":"Sanyal","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.bbr.2018.08.006_bib0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/DDDT.S10180","article-title":"Liraglutide in the management of type 2 diabetes","volume":"4","author":"Wajcberg","year":"2010","journal-title":"Drug Des. Devel. Ther."},{"issue":"6","key":"10.1016\/j.bbr.2018.08.006_bib0145","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/jcbfm.1992.127","article-title":"A three-dimensional statistical analysis for CBF activation studies in human brain","volume":"12","author":"Worsley","year":"1992","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbr.2018.08.006_bib0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jad.2016.09.056","article-title":"Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study","volume":"207","author":"Mansur","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.bbr.2018.08.006_bib0155","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrneurol.2014.178","article-title":"Brain connectivity in neurodegenerative diseases--from phenotype to proteinopathy","volume":"10","author":"Pievani","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.bbr.2018.08.006_bib0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.dsx.2018.03.002","article-title":"Glucagon like peptide-1 (GLP-1) likes Alzheimer\u2019s disease","volume":"12","author":"Yildirim Simsir","year":"2018","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.bbr.2018.08.006_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2018.01.040","article-title":"Novel dual GLP-1\/GIP receptor agonists show neuroprotective effects in Alzheimer\u2019s and Parkinson\u2019s disease models","author":"Holscher","year":"2018","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.bbr.2018.08.006_bib0170","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1476-5381.2012.01971.x","article-title":"Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders","volume":"166","author":"Salcedo","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2018.08.006_bib0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","article-title":"Insulin Resistance and Alzheimer\u2019s Disease: Bioenergetic Linkages","volume":"9","author":"Neth","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2018.08.006_bib0180","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jalz.2014.03.011","article-title":"Insulin resistance predicts brain amyloid deposition in late middle-aged adults","volume":"11","author":"Willette","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"8","key":"10.1016\/j.bbr.2018.08.006_bib0185","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1002\/hbm.23210","article-title":"Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loading","volume":"37","author":"Ishibashi","year":"2016","journal-title":"Hum. Brain Mapp."},{"issue":"9","key":"10.1016\/j.bbr.2018.08.006_bib0190","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.2337\/db11-1669","article-title":"Resting-state brain functional connectivity is altered in type 2 diabetes","volume":"61","author":"Musen","year":"2012","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.bbr.2018.08.006_bib0195","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.neurobiolaging.2009.12.005","article-title":"Insulin resistance and hippocampal volume in women at risk for Alzheimer\u2019s disease","volume":"32","author":"Rasgon","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.bbr.2018.08.006_bib0200","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-016-3874-y","volume":"59","author":"Farr","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbr.2018.08.006_bib0205","first-page":"7","article-title":"The central GLP-1: implications for food and drug reward","author":"Skibicka","year":"2013","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.bbr.2018.08.006_bib0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181400","article-title":"Effects of glucose, insulin, and insulin resistance on cerebral 18F-FDG distribution in cognitively normal older subjects","volume":"12","author":"Ishibashi","year":"2017","journal-title":"PLoS ONE"},{"issue":"13","key":"10.1016\/j.bbr.2018.08.006_bib0215","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1073\/pnas.0308627101","article-title":"Default-mode network activity distinguishes Alzheimer\u2019s disease from healthy aging: evidence from functional MRI","volume":"101","author":"Greicius","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"40","key":"10.1016\/j.bbr.2018.08.006_bib0220","doi-asserted-by":"crossref","first-page":"12686","DOI":"10.1523\/JNEUROSCI.3189-09.2009","article-title":"Disruption of functional connectivity in clinically normal older adults harboring amyloid burden","volume":"29","author":"Hedden","year":"2009","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2018.08.006_bib0225","doi-asserted-by":"crossref","first-page":"17490","DOI":"10.1038\/s41598-017-17718-y","article-title":"Blood-brain glucose transfer in Alzheimer\u2019s disease: effect of GLP-1 analog treatment","volume":"7","author":"Gejl","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bbr.2018.08.006_bib0230","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s11011-017-0059-4","article-title":"Beneficial effects of liraglutide (GLP1 analog) in the hippocampal inflammation","volume":"32","author":"Barreto-Vianna","year":"2017","journal-title":"Metab. Brain Dis."},{"issue":"6","key":"10.1016\/j.bbr.2018.08.006_bib0235","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/jnc.13169","article-title":"Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice","volume":"135","author":"Li","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2018.08.006_bib0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbr.2017.01.004","article-title":"Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects","volume":"321","author":"Palleria","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.08.006_bib0245","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/nyas.12807","article-title":"Impact of diabetes on cognitive function and brain structure","volume":"1353","author":"Moheet","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.bbr.2018.08.006_bib0250","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.biopsych.2009.08.024","article-title":"Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly","volume":"67","author":"Sheline","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2018.08.006_bib0255","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"28","key":"10.1016\/j.bbr.2018.08.006_bib0260","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1073\/pnas.1602413113","article-title":"Cluster failure: why fMRI inferences for spatial extent have inflated false-positive rates","volume":"113","author":"Eklund","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818306430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818306430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:11:17Z","timestamp":1759065077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432818306430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":52,"alternative-id":["S0166432818306430"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2018.08.006","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neural correlates of liraglutide effects in persons at risk for Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2018.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}